Please login to the form below

Not currently logged in
Email:
Password:

Rienso

This page shows the latest Rienso news and features for those working in and with pharma, biotech and healthcare.

Amag buys into maternal health business

Amag buys into maternal health business

Feraheme is sold outside the US by Takeda as Rienso and was approved in Europe in 2012.

Latest news

  • Death leads to recall of batch of Takeda's Rienso in Switzerland Death leads to recall of batch of Takeda's Rienso in Switzerland

    Both Amag and Takeda are now investigating the Swiss batch of Rienso, while the introduction of new batches will depend on approval by Swiss health regulator Swissmedic. ... Rienso is sold as Feraheme in the US and Canada, where Takeda is the exclusive

  • SMC approves Eliquis, restricts use of Rienso SMC approves Eliquis, restricts use of Rienso

    The Scottish Medicines Consortium (SMC) has accepted Eliquis, Pfizer and Bristol-Myers Squibb's anticoagulant, and backed the restricted use of Takeda's anaemia drug Rienso within NHS Scotland. ... it. “Acceptance of Rienso by the SMC marks an

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics